Pfizer just got some backup on its quest to snag a nod for ulcerative colitis med Xeljanz. On Thursday, the FDA’s GI drugs advisory committee voted unanimously to approve the drug, even recommending a green light for a higher 10-mg dose.Original Article
Despite FDA concerns, Pfizer’s Xeljanz wins unanimous AdComm backing in ulcerative colitis
